The Molecular Oncology Program is a network of basic and applied scientists focused on understanding the molecular basis and fundamental processes associated with the biology of cancer cells. It is one of the two major science components of the Cancer Center (Cancer Biology in Animals is the other), which provides expertise and resources in molecular genetics, cell biology and biochemistry to other members of the Cancer Center. There are 41 members from more than 11 departments and centers. By design, they are primarily basic scientists; highly interactive, most of these scientists have collaborative projects with members of other Cancer Center programs. The Program is centered around two major research themes: 1) Kinase signaling and receptor crosstalks and 2) DNA damage and cell-cycle checkpoint. These themes are connected by common research interests in cellular signals and responses to environmental cues and carcinogenic assaults, with the common objective to understand the chemical, biochemical, and molecular basis of these processes. The Program goals include: 1) advancing the understanding of the molecular and chemical basis of cancer transformation and progression, 2) promoting the rapid translation of basic discoveries of cancer mechanisms to the development of potential prognostic markers and therapeutic strategies, and 3) providing molecular biology and biochemistry expertise to Cancer Center and fostering interactions with other programs to develop disease-oriented translational research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
1P30CA093373-01
Application #
6599354
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-07-01
Project End
2005-06-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Wang, Guobao; Corwin, Michael T; Olson, Kristin A et al. (2018) Dynamic PET of human liver inflammation: impact of kinetic modeling with optimization-derived dual-blood input function. Phys Med Biol 63:155004
Winer, Rachel L; Tiro, Jasmin A; Miglioretti, Diana L et al. (2018) Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system. Contemp Clin Trials 64:77-87
Withers, Sita S; Skorupski, Katherine A; York, Daniel et al. (2018) Association of macrophage and lymphocyte infiltration with outcome in canine osteosarcoma. Vet Comp Oncol :
Floc'h, Nicolas; Martin, Matthew J; Riess, Jonathan W et al. (2018) Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions. Mol Cancer Ther 17:885-896
Shih, Tsung-Chieh; Liu, Ruiwu; Wu, Chun-Te et al. (2018) Targeting Galectin-1 Impairs Castration-Resistant Prostate Cancer Progression and Invasion. Clin Cancer Res 24:4319-4331
Weiss, Robert H (2018) Metabolomics and Metabolic Reprogramming in Kidney Cancer. Semin Nephrol 38:175-182
Hegde, John V; Shaverdian, Narek; Daly, Megan E et al. (2018) Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial. Cancer 124:521-529
Arun, Adith S; Tepper, Clifford G; Lam, Kit S (2018) Identification of integrin drug targets for 17 solid tumor types. Oncotarget 9:30146-30162
Tepper, Clifford G; Dang, Julie H T; Stewart, Susan L et al. (2018) High frequency of the PNPLA3 rs738409 [G] single-nucleotide polymorphism in Hmong individuals as a potential basis for a predisposition to chronic liver disease. Cancer 124 Suppl 7:1583-1589
Jerant, Anthony; Fenton, Joshua J; Kravitz, Richard L et al. (2018) Association of Clinician Denial of Patient Requests With Patient Satisfaction. JAMA Intern Med 178:85-91

Showing the most recent 10 out of 836 publications